Wugen

Wugen, Inc. is a St. Louis, Missouri clinical-stage cell-therapy company founded in 2018 out of Washington University in St. Louis that develops off-the-shelf, allogeneic CAR-T and memory NK cell therapies for blood cancers, using CRISPR deletion of the T-cell receptor so cells from healthy donors can be given without graft-versus-host disease. In July 2026 the company renamed itself Allotera Therapeutics, Inc. and moved to alloteratx.com, closing a $35M financing that brought total capital raised to roughly $150M on top of its $115M Series C; its lead program, soficabtagene geleucel (sofi-cel, formerly WU-CART-007), is a CD7-targeted allogeneic CAR-T in a global pivotal study for relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, holds FDA Breakthrough Therapy designation, and was selected for the FDA CMC Development and Readiness Pilot Program. Wugen/Allotera publishes no product or developer API, no OpenAPI, no llms.txt and no agent card. The only machine-readable surface either domain exposes is the WordPress REST API (wp/v2), anonymously readable on both the current alloteratx.com site and the retired wugen.com brand domain, which still serves the complete historical press-release and scientific-publication archive as JSON even though its human-facing site is now a single splash page.

Wugen publishes 7 APIs on the APIs.io network, including Comments API, Discovery API, Media API, and 4 more. Tagged areas include Company, Biotechnology, Cell Therapy, Oncology, and Life Sciences.

Wugen’s developer surface includes authentication, code examples, product news, support, and 27 more developer resources.

27.2/100 emerging ▬ flat Agent 37/100 agent ready Full breakdown ↓
scored 2026-08-12 · rubric v0.11.0
7 APIs
CompanyBiotechnologyCell TherapyOncologyLife SciencesPharmaceuticalsClinical TrialsCAR-TCRISPRImmunotherapyResearchContent

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-12 · rubric v0.11.0
Composite quality — 27.2/100 · emerging
Contract Quality 9.6 / 21
Developer Ergonomics 2.9 / 17
Commercial Clarity 1.8 / 17
Operational Transparency 0.0 / 11
Governance 1.2 / 10
Discoverability 7.9 / 9
Regulatory Posture 3.9 / 15
Agent readiness — 37/100 · agent ready
Machine-Readable Contract 18 / 18
Agentic Access Contract 10 / 10
MCP Server 0 / 12
Machine-Readable Auth 10 / 10
Idempotency 0 / 9
Stable Error Semantics 8 / 8
Request/Response Examples 7 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 5 / 5
Well-Known Catalog 4 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/wugen: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

APIs 7

Individual APIs this provider publishes, each with its own machine-readable definition.

Wugen Comments API

The Comments API from Wugen — 2 operation(s) for comments.

Wugen Discovery API

The Discovery API from Wugen — 7 operation(s) for discovery.

Wugen Media API

The Media API from Wugen — 2 operation(s) for media.

Wugen Pages API

The Pages API from Wugen — 2 operation(s) for pages.

Wugen Posts API

The Posts API from Wugen — 2 operation(s) for posts.

Wugen Search API

The Search API from Wugen — 1 operation(s) for search.

Wugen Taxonomy API

The Taxonomy API from Wugen — 4 operation(s) for taxonomy.

Scroll for all 7

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Wugen Authentication

0 schemes

SECURITY

Wugen Domain Security

TLSv1.3 · DMARC

SECURITY

Agentic Access 1

Recommended x-agentic-access execution contracts for AI agents.

Wugen Agentic Access

38 operations

38 operations · 0 acting

AGENTIC

Resources

Agent Surfaces 4

MCP servers, agent skills, and machine-readable catalogs

Design & Contract 5

Pagination, idempotency, versioning, errors, and events

Build 1

SDKs, sample code, and the tooling you integrate with

Access & Security 2

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 9

The organization behind the API

Scroll for all 9

Other 8

Properties that don't map to a standard resource type

Scroll for all 8

Source (apis.yml)

apis.yml Raw ↑
aid: wugen
name: Wugen
description: Wugen, Inc. is a St. Louis, Missouri clinical-stage cell-therapy company founded in 2018 out of Washington University
  in St. Louis that develops off-the-shelf, allogeneic CAR-T and memory NK cell therapies for blood cancers, using CRISPR
  deletion of the T-cell receptor so cells from healthy donors can be given without graft-versus-host disease. In July 2026
  the company renamed itself Allotera Therapeutics, Inc. and moved to alloteratx.com, closing a $35M financing that brought
  total capital raised to roughly $150M on top of its $115M Series C; its lead program, soficabtagene geleucel (sofi-cel,
  formerly WU-CART-007), is a CD7-targeted allogeneic CAR-T in a global pivotal study for relapsed or refractory T-cell acute
  lymphoblastic leukemia and T-cell lymphoblastic lymphoma, holds FDA Breakthrough Therapy designation, and was selected for
  the FDA CMC Development and Readiness Pilot Program. Wugen/Allotera publishes no product or developer API, no OpenAPI, no
  llms.txt and no agent card. The only machine-readable surface either domain exposes is the WordPress REST API (wp/v2), anonymously
  readable on both the current alloteratx.com site and the retired wugen.com brand domain, which still serves the complete
  historical press-release and scientific-publication archive as JSON even though its human-facing site is now a single splash
  page.
url: https://raw.githubusercontent.com/api-evangelist/wugen/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pipeline
image: https://alloteratx.com/wp-content/uploads/2026/06/Asset-1.svg
specificationVersion: '0.20'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Cell Therapy
- Oncology
- Life Sciences
- Pharmaceuticals
- Clinical Trials
- CAR-T
- CRISPR
- Immunotherapy
- Research
- Content
apis:
- aid: wugen:wugen-comments-api
  name: Wugen Comments API
  description: The Comments API from Wugen — 2 operation(s) for comments.
  humanURL: https://alloteratx.com/press-releases/
  baseURL: https://alloteratx.com/wp-json/wp/v2
  tags:
  - Comments
  properties:
  - type: OpenAPI
    url: openapi/wugen-comments-api-openapi.yml
- aid: wugen:wugen-discovery-api
  name: Wugen Discovery API
  description: The Discovery API from Wugen — 7 operation(s) for discovery.
  humanURL: https://alloteratx.com/press-releases/
  baseURL: https://alloteratx.com/wp-json/wp/v2
  tags:
  - Discovery
  properties:
  - type: OpenAPI
    url: openapi/wugen-discovery-api-openapi.yml
- aid: wugen:wugen-media-api
  name: Wugen Media API
  description: The Media API from Wugen — 2 operation(s) for media.
  humanURL: https://alloteratx.com/press-releases/
  baseURL: https://alloteratx.com/wp-json/wp/v2
  tags:
  - Media
  properties:
  - type: OpenAPI
    url: openapi/wugen-media-api-openapi.yml
- aid: wugen:wugen-pages-api
  name: Wugen Pages API
  description: The Pages API from Wugen — 2 operation(s) for pages.
  humanURL: https://alloteratx.com/press-releases/
  baseURL: https://alloteratx.com/wp-json/wp/v2
  tags:
  - Pages
  properties:
  - type: OpenAPI
    url: openapi/wugen-pages-api-openapi.yml
- aid: wugen:wugen-posts-api
  name: Wugen Posts API
  description: The Posts API from Wugen — 2 operation(s) for posts.
  humanURL: https://alloteratx.com/press-releases/
  baseURL: https://alloteratx.com/wp-json/wp/v2
  tags:
  - Posts
  properties:
  - type: OpenAPI
    url: openapi/wugen-posts-api-openapi.yml
- aid: wugen:wugen-search-api
  name: Wugen Search API
  description: The Search API from Wugen — 1 operation(s) for search.
  humanURL: https://alloteratx.com/press-releases/
  baseURL: https://alloteratx.com/wp-json/wp/v2
  tags:
  - Search
  properties:
  - type: OpenAPI
    url: openapi/wugen-search-api-openapi.yml
- aid: wugen:wugen-taxonomy-api
  name: Wugen Taxonomy API
  description: The Taxonomy API from Wugen — 4 operation(s) for taxonomy.
  humanURL: https://alloteratx.com/press-releases/
  baseURL: https://alloteratx.com/wp-json/wp/v2
  tags:
  - Taxonomy
  properties:
  - type: OpenAPI
    url: openapi/wugen-taxonomy-api-openapi.yml
x-enrichment:
  date: '2026-08-05'
  status: enriched
  artifacts_added: 21
  pass: local-v1
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Overlay
  url: overlays/wugen-allotera-content-overlay.yaml
- type: AgenticAccess
  url: agentic-access/wugen-agentic-access.yml
- type: DomainSecurity
  url: security/wugen-domain-security.yml
- type: Authentication
  url: authentication/wugen-authentication.yml
- type: Conventions
  url: conventions/wugen-conventions.yml
- type: Conformance
  url: conformance/wugen-conformance.yml
- type: Lifecycle
  url: lifecycle/wugen-lifecycle.yml
- type: ErrorCatalog
  url: errors/wugen-problem-types.yml
- type: DataModel
  url: data-model/wugen-data-model.yml
- type: Examples
  url: examples/wugen-examples.yml
- type: WellKnown
  url: well-known/wugen-well-known.yml
- type: LLMsTxt
  url: llms/wugen-llms.txt
- type: AgentSkill
  url: skills/_index.yml
- type: Website
  url: https://alloteratx.com/
- type: BlogRSS
  url: https://alloteratx.com/feed/
- type: FormerWebsite
  url: https://wugen.com/
- type: About
  url: https://alloteratx.com/about-us/
- type: Technology
  url: https://alloteratx.com/science/
- type: Pipeline
  url: https://alloteratx.com/pipeline/
- type: News
  url: https://alloteratx.com/press-releases/
- type: Publications
  url: https://alloteratx.com/scientific-publications/
- type: Team
  url: https://alloteratx.com/leadership/
- type: Board
  url: https://alloteratx.com/board-of-directors/
- type: Investors
  url: https://alloteratx.com/investors/
- type: Partners
  url: https://alloteratx.com/partners/
- type: Careers
  url: https://alloteratx.com/career-opportunities/
- type: Support
  url: https://alloteratx.com/contact-us/
- type: PrivacyPolicy
  url: https://alloteratx.com/privacy-notice/
- type: Accessibility
  url: https://alloteratx.com/accessibility/
- type: LinkedIn
  url: https://www.linkedin.com/company/wugen
- type: SecondaryMarket
  url: https://forgeglobal.com/wugen_stock/